LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: [A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits].

    Uemoto, Yuri / Shiraishi, Wataru / Fujiki, Ryosuke / Furuta, Konosuke

    Journal of UOEH

    2021  Volume 43, Issue 2, Page(s) 255–261

    Abstract: We present a case of a 59-year-old female who had been treated for optic neuritis 2 years before being transferred to our hospital. She had been positive for anti-AQP4 antibodies. No cerebrospinal lesions were observed, and based on the diagnosis of ... ...

    Abstract We present a case of a 59-year-old female who had been treated for optic neuritis 2 years before being transferred to our hospital. She had been positive for anti-AQP4 antibodies. No cerebrospinal lesions were observed, and based on the diagnosis of neuromyelitis optica spectrum disorder (NMOSD), 5 mg/day oral prednisolone was continued for 2 years. Acute lower back pain and urinary retention appeared on day X. On day X + 1, consciousness disturbance (JCS level II) and paraplegia appeared, and she was transferred to our hospital. Neck stiffness, paraplegia, and urinary retention were present. A cerebrospinal fluid examination revealed mononucleosis-dominant pleocytosis (1,232 cells/μl). Brain magnetic resonance imaging (MRI) showed multiple lesions around the ventricles and corpus callosum, and spinal MRI revealed a longitudinally extensive transverse myelitis lesion (C2-Th5). A relapse of NMOSD was diagnosed and steroid pulse therapy was started, but the symptoms progressed and quadriplegia and coma occurred. Head MRI showed new deep white matter lesions around the ventricles. Plasma exchange was added after the second steroid pulse. The patient's consciousness gradually improved, and spontaneous movement of the left upper limb eventually appeared. We experienced a case of NMOSD that relapsed with multiple cerebrospinal lesions despite corticosteroid therapy, but plasmapheresis therapy was effective.
    MeSH term(s) Adrenal Cortex Hormones ; Aquaporin 4 ; Autoantibodies ; Brain ; Female ; Humans ; Magnetic Resonance Imaging ; Middle Aged ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/drug therapy
    Chemical Substances Adrenal Cortex Hormones ; Aquaporin 4 ; Autoantibodies
    Language Japanese
    Publishing date 2021-06-07
    Publishing country Japan
    Document type Case Reports ; Journal Article
    ZDB-ID 632724-2
    ISSN 2187-2864 ; 0387-821X
    ISSN (online) 2187-2864
    ISSN 0387-821X
    DOI 10.7888/juoeh.43.255
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Allogeneic stem cell transplantation for trisomy 8-positive myelodysplastic syndrome or myelodysplastic/myeloproliferative disease with refractory Behçet's disease: Case report and the review of literature.

    Onaka, Takashi / Nakano, Kazuhisa / Uemoto, Yuri / Miyakawa, Naoto / Otsuka, Yasuyuki / Ogura-Kato, Aiko / Iwai, Fumie / Tanaka, Yoshiya / Yonezawa, Akihito

    Modern rheumatology case reports

    2022  Volume 6, Issue 2, Page(s) 273–277

    Abstract: We had two cases of trisomy 8-positive myelodysplastic syndrome (MDS) with incomplete Behçet's disease (BD) in which the remissions of both diseases were maintained by allogeneic stem cell transplantation (allo-SCT). Among MDS with BD patients, sometimes ...

    Abstract We had two cases of trisomy 8-positive myelodysplastic syndrome (MDS) with incomplete Behçet's disease (BD) in which the remissions of both diseases were maintained by allogeneic stem cell transplantation (allo-SCT). Among MDS with BD patients, sometimes it is difficult to control the symptoms of BD with standard therapies such as corticosteroids and tumor necrosis factor (TNF) inhibitors. Although there should be careful consideration regarding indications for transplantation, our two cases, in which refractory BD was completely controlled by allo-SCT, suggest that allo-SCT can be one of the treatment options for higher-risk MDS with BD patients.
    MeSH term(s) Behcet Syndrome/complications ; Behcet Syndrome/diagnosis ; Behcet Syndrome/therapy ; Chromosomes, Human, Pair 8 ; Hematopoietic Stem Cell Transplantation/adverse effects ; Humans ; Myelodysplastic Syndromes/complications ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/therapy ; Trisomy
    Language English
    Publishing date 2022-04-01
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ISSN 2472-5625
    ISSN (online) 2472-5625
    DOI 10.1093/mrcr/rxac032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top